Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma

Published:2016-12-12 Issue:7 Volume:27 Page:3069-3079
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Chen Bang-Bin,Hsu Chao-Yu,Yu Chih-Wei,Liang Po-Chin,Hsu Chiun,Hsu Chih-Hung,Cheng Ann-Lii,Shih Tiffany Ting-Fang

Funder

National Taiwan University Hospital (TW)

the Ministry of Science and Technology, Executive Yuan, ROC, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00330-016-4670-2/fulltext.html

Reference43 articles.

1. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491

2. Chen KW, Ou TM, Hsu CW et al (2015) Current systemic treatment of hepatocellular carcinoma: a review of the literature. World J Hepatol 7:1412–1420

3. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34

4. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

5. Deng GL, Zeng S, Shen H (2015) Chemotherapy and target therapy for hepatocellular carcinoma: new advances and challenges. World J Hepatol 7:787–798

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of quantitative perfusion MRI in the liver;Advances in Magnetic Resonance Technology and Applications;2023

2. Early Diagnosis Value of DCE-MRI Hemodynamic Parameters in Hepatocellular Carcinoma;Journal of Oncology;2022-05-13

3. DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer;Discover Oncology;2022-01-08

4. Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials;Cancers;2021-10-01

5. Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma;Diagnostics;2021-07-26